Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Supplemental Oxygen in Pulmonary Embolism
NCT05891886Phase 1Recruiting
- Sponsor
- Massachusetts General Hospital
- Start
- Oct 2023
- Primary completion
- Jun 2027
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of oxygen in pulmonary embolism (PE) (2 arms), sponsored by Massachusetts General Hospital. Primary endpoint: Pulmonary artery systolic pressure at 180 minutes. Started Oct 2023; status: recruiting.
02
Drugs
oxygen
03
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT05891886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05891886.